Technical Analysis for ARVN - Arvinas, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Historical ARVN trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Gapped Down | Weakness | 0.18% | |
| 50 DMA Resistance | Bearish | -3.15% | |
| Fell Below 20 DMA | Bearish | -3.15% | |
| 50 DMA Resistance | Bearish | -6.10% | |
| Crossed Above 20 DMA | Bullish | -6.10% | |
| MACD Bullish Signal Line Cross | Bullish | -6.10% | |
| Multiple of Ten Bearish | Other | -6.10% | |
| Gapped Up | Strength | -6.10% | |
| Up 3 Days in a Row | Strength | -6.10% | |
| Stochastic Buy Signal | Bullish | -2.88% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Up 1% | about 2 hours ago |
| Fell Below Previous Day's Low | about 4 hours ago |
| Down 1% | about 4 hours ago |
| Possible NR7 | about 24 hours ago |
| 10 DMA Support | 1 day ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/03/2021
Arvinas Inc. is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Arvinas uses its proprietary technology platform to engineer proteolysis targeting chimeras, or PROTAC™ protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Diseases Genetics Proprietary Technology Metabolism Androgen Receptor Chimera
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Diseases Genetics Proprietary Technology Metabolism Androgen Receptor Chimera
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 108.43 |
| 52 Week Low | 19.68 |
| Average Volume | 313,787 |
| 200-Day Moving Average | 78.52 |
| 50-Day Moving Average | 87.80 |
| 20-Day Moving Average | 85.61 |
| 10-Day Moving Average | 83.65 |
| Average True Range | 3.60 |
| ADX | 17.74 |
| +DI | 22.13 |
| -DI | 29.08 |
| Chandelier Exit (Long, 3 ATRs) | 86.41 |
| Chandelier Exit (Short, 3 ATRs) | 91.64 |
| Upper Bollinger Bands | 93.33 |
| Lower Bollinger Band | 77.89 |
| Percent B (%b) | 0.28 |
| BandWidth | 18.04 |
| MACD Line | -1.48 |
| MACD Signal Line | -1.53 |
| MACD Histogram | 0.0468 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 86.10 | ||||
| Resistance 3 (R3) | 86.42 | 85.46 | 85.46 | ||
| Resistance 2 (R2) | 85.46 | 84.49 | 85.30 | 85.24 | |
| Resistance 1 (R1) | 83.87 | 83.89 | 83.39 | 83.55 | 85.03 |
| Pivot Point | 82.91 | 82.91 | 82.68 | 82.75 | 82.91 |
| Support 1 (S1) | 81.32 | 81.94 | 80.84 | 81.00 | 79.51 |
| Support 2 (S2) | 80.36 | 81.34 | 80.20 | 79.30 | |
| Support 3 (S3) | 78.77 | 80.36 | 79.08 | ||
| Support 4 (S4) | 78.45 |
